262 related articles for article (PubMed ID: 32712275)
1. Positive allosteric modulators that target NMDA receptors rectify loss-of-function GRIN variants associated with neurological and neuropsychiatric disorders.
Tang W; Liu D; Traynelis SF; Yuan H
Neuropharmacology; 2020 Oct; 177():108247. PubMed ID: 32712275
[TBL] [Abstract][Full Text] [Related]
2. De novo GRIN variants in NMDA receptor M2 channel pore-forming loop are associated with neurological diseases.
Li J; Zhang J; Tang W; Mizu RK; Kusumoto H; XiangWei W; Xu Y; Chen W; Amin JB; Hu C; Kannan V; Keller SR; Wilcox WR; Lemke JR; Myers SJ; Swanger SA; Wollmuth LP; Petrovski S; Traynelis SF; Yuan H
Hum Mutat; 2019 Dec; 40(12):2393-2413. PubMed ID: 31429998
[TBL] [Abstract][Full Text] [Related]
3. Novel neuroactive steroids as positive allosteric modulators of NMDA receptors: mechanism, site of action, and rescue pharmacology on GRIN variants associated with neurological conditions.
Tang W; Beckley JT; Zhang J; Song R; Xu Y; Kim S; Quirk MC; Robichaud AJ; Diaz ES; Myers SJ; Doherty JJ; Ackley MA; Traynelis SF; Yuan H
Cell Mol Life Sci; 2023 Jan; 80(2):42. PubMed ID: 36645496
[TBL] [Abstract][Full Text] [Related]
4. Disease-associated GRIN protein truncating variants trigger NMDA receptor loss-of-function.
Santos-Gómez A; Miguez-Cabello F; García-Recio A; Locubiche-Serra S; García-Díaz R; Soto-Insuga V; Guerrero-López R; Juliá-Palacios N; Ciruela F; García-Cazorla À; Soto D; Olivella M; Altafaj X
Hum Mol Genet; 2021 Feb; 29(24):3859-3871. PubMed ID: 33043365
[TBL] [Abstract][Full Text] [Related]
5. Molecular Mechanism of Disease-Associated Mutations in the Pre-M1 Helix of NMDA Receptors and Potential Rescue Pharmacology.
Ogden KK; Chen W; Swanger SA; McDaniel MJ; Fan LZ; Hu C; Tankovic A; Kusumoto H; Kosobucki GJ; Schulien AJ; Su Z; Pecha J; Bhattacharya S; Petrovski S; Cohen AE; Aizenman E; Traynelis SF; Yuan H
PLoS Genet; 2017 Jan; 13(1):e1006536. PubMed ID: 28095420
[TBL] [Abstract][Full Text] [Related]
6. Recurrent seizure-related GRIN1 variant: Molecular mechanism and targeted therapy.
Xu Y; Song R; Chen W; Strong K; Shrey D; Gedela S; Traynelis SF; Zhang G; Yuan H
Ann Clin Transl Neurol; 2021 Jul; 8(7):1480-1494. PubMed ID: 34227748
[TBL] [Abstract][Full Text] [Related]
7. Rescuing tri-heteromeric NMDA receptor function: the potential of pregnenolone-sulfate in loss-of-function GRIN2B variants.
Kellner S; Berlin S
Cell Mol Life Sci; 2024 May; 81(1):235. PubMed ID: 38795169
[TBL] [Abstract][Full Text] [Related]
8. Pregnane-based steroids are novel positive NMDA receptor modulators that may compensate for the effect of loss-of-function disease-associated GRIN mutations.
Kysilov B; Hrcka Krausova B; Vyklicky V; Smejkalova T; Korinek M; Horak M; Chodounska H; Kudova E; Cerny J; Vyklicky L
Br J Pharmacol; 2022 Aug; 179(15):3970-3990. PubMed ID: 35318645
[TBL] [Abstract][Full Text] [Related]
9. Opportunities for Precision Treatment of
Han W; Yuan H; Allen JP; Kim S; Shaulsky GH; Perszyk RE; Traynelis SF; Myers SJ
J Pharmacol Exp Ther; 2022 Apr; 381(1):54-66. PubMed ID: 35110392
[TBL] [Abstract][Full Text] [Related]
10. Functional effects of disease-associated variants reveal that the S1-M1 linker of the NMDA receptor critically controls channel opening.
Xie L; McDaniel MJ; Perszyk RE; Kim S; Cappuccio G; Shapiro KA; Muñoz-Cabello B; Sanchez-Lara PA; Grand K; Zhang J; Nocilla KA; Sheikh R; Armengol L; Romano R; Pierson TM; Yuan H; Myers SJ; Traynelis SF
Cell Mol Life Sci; 2023 Mar; 80(4):110. PubMed ID: 37000222
[TBL] [Abstract][Full Text] [Related]
11. Chimeric Glutamate Receptor Subunits Reveal the Transmembrane Domain Is Sufficient for NMDA Receptor Pore Properties but Some Positive Allosteric Modulators Require Additional Domains.
Wilding TJ; Lopez MN; Huettner JE
J Neurosci; 2016 Aug; 36(34):8815-25. PubMed ID: 27559165
[TBL] [Abstract][Full Text] [Related]
12. Positive Allosteric Modulation as a Potential Therapeutic Strategy in Anti-NMDA Receptor Encephalitis.
Warikoo N; Brunwasser SJ; Benz A; Shu HJ; Paul SM; Lewis M; Doherty J; Quirk M; Piccio L; Zorumski CF; Day GS; Mennerick S
J Neurosci; 2018 Mar; 38(13):3218-3229. PubMed ID: 29476014
[No Abstract] [Full Text] [Related]
13. De novo GRIN variants in M3 helix associated with neurological disorders control channel gating of NMDA receptor.
Xu Y; Song R; Perszyk RE; Chen W; Kim S; Park KL; Allen JP; Nocilla KA; Zhang J; XiangWei W; Tankovic A; McDaniels ED; Sheikh R; Mizu RK; Karamchandani MM; Hu C; Kusumoto H; Pecha J; Cappuccio G; Gaitanis J; Sullivan J; Shashi V; Petrovski S; Jauss RT; Lee HK; Bozarth X; Lynch DR; Helbig I; Pierson TM; Boerkoel CF; Myers SJ; Lemke JR; Benke TA; Yuan H; Traynelis SF
Cell Mol Life Sci; 2024 Mar; 81(1):153. PubMed ID: 38538865
[TBL] [Abstract][Full Text] [Related]
14. GRIN2B gain of function mutations are sensitive to radiprodil, a negative allosteric modulator of GluN2B-containing NMDA receptors.
Mullier B; Wolff C; Sands ZA; Ghisdal P; Muglia P; Kaminski RM; André VM
Neuropharmacology; 2017 Sep; 123():322-331. PubMed ID: 28533163
[TBL] [Abstract][Full Text] [Related]
15. A Novel Negative Allosteric Modulator Selective for GluN2C/2D-Containing NMDA Receptors Inhibits Synaptic Transmission in Hippocampal Interneurons.
Swanger SA; Vance KM; Acker TM; Zimmerman SS; DiRaddo JO; Myers SJ; Bundgaard C; Mosley CA; Summer SL; Menaldino DS; Jensen HS; Liotta DC; Traynelis SF
ACS Chem Neurosci; 2018 Feb; 9(2):306-319. PubMed ID: 29043770
[TBL] [Abstract][Full Text] [Related]
16. Allosteric modulators of NMDA receptors: multiple sites and mechanisms.
Zhu S; Paoletti P
Curr Opin Pharmacol; 2015 Feb; 20():14-23. PubMed ID: 25462287
[TBL] [Abstract][Full Text] [Related]
17. The NMDA receptor intracellular C-terminal domains reciprocally interact with allosteric modulators.
Sapkota K; Dore K; Tang K; Irvine M; Fang G; Burnell ES; Malinow R; Jane DE; Monaghan DT
Biochem Pharmacol; 2019 Jan; 159():140-153. PubMed ID: 30503374
[TBL] [Abstract][Full Text] [Related]
18. Classification of missense variants in the N-methyl-d-aspartate receptor GRIN gene family as gain- or loss-of-function.
Myers SJ; Yuan H; Perszyk RE; Zhang J; Kim S; Nocilla KA; Allen JP; Bain JM; Lemke JR; Lal D; Benke TA; Traynelis SF
Hum Mol Genet; 2023 Sep; 32(19):2857-2871. PubMed ID: 37369021
[TBL] [Abstract][Full Text] [Related]
19. Distinct roles of
Myers SJ; Yuan H; Kang JQ; Tan FCK; Traynelis SF; Low CM
F1000Res; 2019; 8():. PubMed ID: 31807283
[TBL] [Abstract][Full Text] [Related]
20. A Rare Variant Identified Within the GluN2B C-Terminus in a Patient with Autism Affects NMDA Receptor Surface Expression and Spine Density.
Liu S; Zhou L; Yuan H; Vieira M; Sanz-Clemente A; Badger JD; Lu W; Traynelis SF; Roche KW
J Neurosci; 2017 Apr; 37(15):4093-4102. PubMed ID: 28283559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
